• Return to Headlines

Biomarin Pharmac Has Returned 9.3% Since SmarTrend Recommendation (BMRN)

By Shiri Gupta

SmarTrend identified an Uptrend for Biomarin Pharmac (NASDAQ:BMRN) on October 24th, 2019 at $69.90. In approximately 3 weeks, Biomarin Pharmac has returned 9.26% as of today's recent price of $76.37.

Over the past year, Biomarin Pharmac has traded in a range of $62.88 to $100.13 and is now at $76.37, 21% above that low. Over the past week, the 200-day moving average (MA) has gone down 0.4% while the 50-day MA has remained constant.

BioMarin Pharmaceutical, Inc., a biotechnology company, develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Biomarin Pharmac shares.

Log in and add Biomarin Pharmac (BMRN) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights biomarin pharmac

Ticker(s): BMRN